TUBA4A and myopathy: Through in silico, in vitro, histopathological and immunohistochemical analyses, we characterise the phenotypic and molecular spectrum of TUBA4A-related myopathies and multisystem proteinopathies – henceforth referred to as ‘myo-tubulinopathies’.